Rapport Therapeutics

United States
Panora, Iowa, United States, 02215

Company profile

Rapport Therapeutics company profile

Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.

Business identity

Phone number
(857) 321-8020
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2022-01-01, Year

Headquarters

Postal code
02215
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$500M
Last funding
Post IPO Equity / $250M / 2025-09-09
Last equity funding
Post IPO Equity / $250M
Investors
11
Lead investors
2
Founders
2
Articles
152
Exited on
2024-06-07

Founders and investors

Founders

David BredtSteven Paul

Lead investors

Cormorant Asset ManagementThird Rock Ventures

Investors

ARCH Venture PartnersCormorant Asset ManagementFidelityPerceptive AdvisorsT. Rowe Price